相关实验视频
Updated: Jul 28, 2025

03:25
Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
5.6K
可穿戴的电化学葡萄糖传感器在糖尿病管理中:全面的审查
Tamoghna Saha1, Rafael Del Caño1,2, Kuldeep Mahato1
1Department of Nanoengineering, University of California San Diego, La Jolla, California 92093, United States.
Chemical reviews
|May 30, 2023
概括
可穿戴的电化学传感器为糖尿病管理提供了有前途的进展. 这些设备可实现实时,最少侵入性血糖监测,为个性化护理和人工胰腺系统铺平道路.
科学领域:
- 生物医学工程 生物医学工程
- 分析化学 分析化学
- 材料科学 材料科学 材料科学
背景情况:
- 全球糖尿病患病率不断上升,需要先进的葡萄糖监测解决方案.
- 自20世纪60年代以来,电化学生物传感器在糖尿病管理方面发生了显著的进化.
- 可穿戴技术为非侵入性或最小侵入性葡萄糖传感提供了新的可能性.
研究的目的:
- 提供可穿戴电化学传感器用于体内血糖监测的全面审查.
- 通过先进的传感来强调有效的糖尿病管理的重要性.
- 讨论这些传感器在个性化糖尿病护理方面的潜力.
主要方法:
- 电化学葡萄糖传感机制和传感器历史演变的审查.
- 对针对不同生物流体的各种可穿戴生物传感器设计进行分析.
- 检查多重传感器和商业连续血糖监测系统.
主要成果:
- 电化学生物传感器对于实时葡萄糖分析至关重要.
- 使用替代生物流体的可穿戴传感器提供无痛监测.
- 多重传感器和新兴技术增强了糖尿病管理能力.
结论:
- 可穿戴的电化学传感器代表了糖尿病监测的重大进步.
- 这些技术是个性化糖尿病管理和闭环人工胰腺系统的关键.
- 未来的前景包括进一步整合和优化自主血糖控制.
相关概念视频
Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
Diabetes: Symptoms, Diagnosis, and Complications
606
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
606
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Hypoglycemia and Glucagon
306
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
306
Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K

